Serum AGR2 as a useful biomarker for pituitary adenomas

Pituitary adenomas (PAs) account for about 15% of intracranial tumors, although autopsy series have found that the incidence of PAs in the general population may be as high as 25% [1]. Many PAs are incidentally found on imaging scans performed for unrelated reasons. PAs are not difficult to diagnose in other suffering from significant hormone hypersecretion, hypothalamic/pituitary dysfunction and visual field compromise due to their large size [2,3]. However, the opposite is true for the patients with PAs that are completely asymptomatic, and are incidentally found on magnetic resonance imaging (MRI) [4] .

Source: Clinical Neurology and Neurosurgery - January 8, 2017 Category: Neurosurgery Authors: Mamatemin Tohti, Junyang Li, Chao Tang, Guodao Wen, Abdukeyum Abdujilil, Parhat Yizim, Chiyuan Ma Source Type: research